QIAGEN N.V. today announced a series of product and partnership updates designed to strengthen its portfolio for cancer genomic profiling. These new developments will be showcased at the American ...

Agreement enables Bayer to leverage ConcertAI Translational360™ and AI SaaS solutions to leverage insights derived from AI and machine learning CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI announced a ...

The firms will explore molecular mechanisms and patient responses in cancer to inform development of new therapies.

A new computational biology pipeline has mapped out more than 13,000 groups of protein-coding genes conserved across grasses, ...

Andrei Georgescu of Vivodyne discusses key advantages of its humanized drug testing platform and the impact of the FDA’s policy shift.

Ankur Mutreja, Tikesh Bisen, and Balaji Veeraraghavan address the urgent global health challenge of antimicrobial resistance.

ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI's Translational360tm -- powered by Guardant Health liquid biopsy genomic data -- and AI SaaS solutions, which use artificial ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that two oral presentations and a poster presentation featuring data for the company’s NeXT ...

From joint ventures to licensing deals, biotechnology is emerging as a strategic bridge between China and Japan.

Republican lawmakers associated with the House Committee on Energy and Commerce are probing the 23andMe bankruptcy out of ...

Researchers from Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of ...